Higher dose and shorter treatment of key antibiotic proven to be safe for TB patients

A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George’s, University of London and results published in NEJM Evidence.

Is Doctor Pay Too High? NIH Pulls Plug on Misinfo Research; FDA and EPA Butt Heads

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. What Contributes to Doctors’ High Salaries?

August 10, 2023

Breakthrough genome-wide study uncovers new loci impacting apolipoprotein E levels and Alzheimer’s risk

New genetic factors that affect the plasma apolipoprotein E levels.

September 8, 2023

‘What’s your pain right now?’ Sickle cell, loss, and survival in America

You’re reading Part 5 of Coercive Care, a yearlong examination of the denial of reproductive autonomy for people with sickle cell disease. ST. LOUIS —

November 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.